Overview

A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Status:
Completed

Trial end date:
2008-10-01

Target enrollment:

Participant gender:

Summary

This study will assess the safety and efficacy of 5 doses GW642444 in subjects with Chonic Obstructive Pulmonary Disease (COPD)

Phase:

Phase 2

Details

Lead Sponsor:

GlaxoSmithKline